Sodiumtetrakis (pentafluorophenyl)borate dihydrate

IUPAC Name: sodium tetrakis(2,3,4,5,6-pentafluorophenyl)boranuide

Catalog NO.:
CAS NO.: 149213-65-0
Brand: Daisa Biopharma
Category: Catalyst
Tag: Sodiumtetrakis and Catalyst
Molecular Formula: C24BF20Na

Odor: No order

Storage: Inert atmosphere, room temperature

Molecular Weight: 701.93

Pack Size Available: 5 g, 100 g, 1.0 kg

Place of Origin: India

0 People watching this product now!

cGMP Capacity

kg to MT scale
GMP batches production
Over 20 years of experience

HPAPI production with OEL < 1 μg/m³
Cleanroom Class 100 to Class 100,000
Special type of reactions in cGMP workshop

Cleaning level: Class A B C
cGMP synthesis workshop

Product Description

  • Highly active catalysts in reactions such as olefin polymerization.
  • In polymer chemistry and transition-metal catalysis research.
  • Intermediate in medicinal chemistry and fine chemical synthesis.
  • In cationic polymerizations and electrophilic reactions.

Appearance: White to off-white crystalline powder

HPLC purity: ≥98% a/a

Synonyms : Sodium tetrakis(perfluorophenyl)borate

NMR: Confirm the structure

 

Physical Form: Solid

Shipping Temperature: Keep the container tightly closed in a dry, well-ventilated area. Containers that are opened must be carefully resealed and kept upright to prevent leakage. Inert atmosphere, Room Temperature

Storage Temperature: Keep container tightly closed in a dry and well-ventilated area. Containers that are opened must be carefully resealed and kept upright to prevent leakage. Inert atmosphere, Room Temperature

Inchi Code: 1S/C24BF20.Na/c26-5-1(6(27)14(35)21(42)13(5)34)25(2-7(28)15(36)22(43)16(37)8(2)29,3-9(30)17(38)23(44)18(39)10(3)31)4-11(32)19(40)24(45)20(41)12(4)33;/q-1;+1

SMILES: [B-](C1=C(C(=C(C(=C1F)F)F)F)F)(C2=C(C(=C(C(=C2F)F)F)F)F)(C3=C(C(=C(C(=C3F)F)F)F)F)C4=C(C(=C(C(=C4F)F)F)F)F.[Na+]

Reference

23672441

About Us

We are a multidisciplinary research organization specializing in Medicinal Chemistry, Process Chemistry, and Biocatalysis—delivering scalable, efficient, and sustainable solutions for complex scientific challenges.

Our medicinal chemistry division drives early-stage drug discovery through the design and synthesis of novel chemical entities, SAR exploration, and creation of natural-product-inspired molecular libraries.

We develop safe, robust, and scalable synthetic routes for APIs and intermediates. Our expertise covers QbD-driven development, impurity profiling, polymorph optimization, and complete CMC/DMF support.

Our biocatalysis services include enzyme screening, whole-cell bioconversion, and industrial bioprocess scale-up—enabling greener, more cost-effective, and sustainable alternatives to traditional chemical transformations.

Our Clients